Loading...

Challenges in mHealth clinical trials integration

Image

19-Jan-16 Currently, there is no global standard for mHealth in clinical trials, and the use of wearable devices raise regulatory challenges as sponsors question whether regulatory agencies in Asia and globally will accept mHealth data. Of particular concern are the expectations around safety monitoring. [image: BioSpectrum]

Read More

Biomedicine sector looks promising after Taiwan election

Image

18-Jan-16 With policy support and a local talent pool, biomedicine may be the next big thing in Taiwan as President-elect Tsai Ing-wen takes office in May. Biotech is one of the five focus industries to be cultivated by the the new government, which will also invested in the development of drugs, medical instruments and materials. [image: University of Melbourne]

Read More

10% of patients worldwide are affected by errors in medical care

Image

14-Jan-16 Unsafe use of medication is a major issue in both developed and developing countries, causing millions of injuries and costing USD4 bn annually. 10% of patients worldwide are affected, said a WHO report. "A global concerted effort is needed to address patient medication safety... Communication has become the buzzword," said Dr. SD Gupta, President of IIHMR University in Jaipur. [image: Keval News]

Read More

Pneumonia kills 200,000 kids annually in India

Image

06-Jan-16 A new study in the Lancet’s special series on Antimicrobial Resistance shows that only 12.5% of India’s under-five children with suspected pneumonia are actually receiving treatment, resulting in 210,000 deaths every year. “Access to effective antimicrobials: A worldwide challenge” goes on to conclude that India could avert 80.7% of these deaths by universalizing access to antibiotics. [image: The Tribune]

Read More

Kalbe Farma and Kimia Farma to open raw materials plants in Indonesia

Image

05-Jan-16 Indonesia's largest pharmaceutical company, Kalbe Farma, is constructing a biopharmacy raw material manufacturing plant in Cikarang, West Java, scheduled to commence operations in late 2017 or 2018. State-controlled company Kimia Farma also announced recently that it would start constructing a INR100 bn (USD7 mn) raw materials plant in the same location. [image: Kalbe Farma and Kimia Farma]

Read More
Share